Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

HeartWare International presents clinical trial data of Ventricular Assist System at ISHLT annual meeting

Continuous flow mechanical circulatory support devices improve outcomes in patients awaiting heart transplants

Continuous flow mechanical circulatory support devices improve outcomes in patients awaiting heart transplants

SuperSonic Imagine reports results of largest worldwide multicenter clinical breast study in ultrasound imaging

SuperSonic Imagine reports results of largest worldwide multicenter clinical breast study in ultrasound imaging

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Misonix signs exclusive distribution agreement with Suministros Medicos Multimedicas

Misonix signs exclusive distribution agreement with Suministros Medicos Multimedicas

Study finds no decrease in access to medical care for sicker patients needing CABG surgery

Study finds no decrease in access to medical care for sicker patients needing CABG surgery

Advances in understanding of cardiac-specific genes in heart development

Advances in understanding of cardiac-specific genes in heart development

Researchers take major step to predict adverse drug reactions using genetic information

Researchers take major step to predict adverse drug reactions using genetic information

Research associates diabetes with atrial fibrillation

Research associates diabetes with atrial fibrillation

Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010

Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010

Nile Therapeutics prices underwritten public offering of common stock

Nile Therapeutics prices underwritten public offering of common stock

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Pfizer announces discontinuation of SUN 1170 Phase 3 study of Sutent in HCC

Pfizer announces discontinuation of SUN 1170 Phase 3 study of Sutent in HCC

Women and men experience different outcomes at U.S. hospitals: HealthGrades

Women and men experience different outcomes at U.S. hospitals: HealthGrades

"Destination therapy" for end-stage heart failure patients

"Destination therapy" for end-stage heart failure patients

Systems biologists integrate new genetic framework to help predict adverse drug reactions

Systems biologists integrate new genetic framework to help predict adverse drug reactions

Acorda Therapeutics to initiate Phase 1 clinical trial of GGF2 for heart failure in mid-2010

Acorda Therapeutics to initiate Phase 1 clinical trial of GGF2 for heart failure in mid-2010

End-of-life care documentation helps in emergency treatment decisions

End-of-life care documentation helps in emergency treatment decisions

Heart transplant patient skis to the North Pole

Heart transplant patient skis to the North Pole

Research roundup: Revamping NCI Clinical Trials, reducing malpractice suits, health disparities persist

Research roundup: Revamping NCI Clinical Trials, reducing malpractice suits, health disparities persist

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.